South Korea's Lunit, an artificial intelligence (AI) medical software company, on Friday said its board meeting held on the previous day decided to open a subsidiary in Europe dubbed Lunit Europe Holdings.
To be a wholly owned affiliate of Lunit, the Netherlands-based subsidiary will soon start hiring workers from the region.
Lunit previously sold its products through its European branch, but its decision to set up a subsidiary is intended to expand its sales network in Europe and boost tieups with global medical device companies.
If business on the Continent grows, Lunit will set up more companies in major European countries.
"The establishment of Lunit Europe Holdings is a stepping stone to expansion of profitability on the European market through boosting Lunit's global capabilities and brand awareness," said Lunit CEO Suh Beom-seok.
The company's sales last year reached 13.8 billion won ($10.6 million) as Lunit became the first domestic medical AI company to break 10 billion won in revenue.
We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.